Skip to main content
Clinical Trials/NCT07331597
NCT07331597
Completed
Not Applicable

Effects of Scapulothoracic Joint Mobilization With or Without Acromioclavicular Joint Mobilization in Patients With Sub-acromial Pain Syndrome

Riphah International University1 site in 1 country36 target enrollmentStarted: January 10, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
36
Locations
1
Primary Endpoint
Numeric Pain Rating scale

Overview

Brief Summary

the study was conducted to find out the effects of scapulothoracic joint mobilization with or without acromioclavicular joint mobilization in patients with sub-acromial pain syndrome.

Detailed Description

the study was conducted to determine the effects on the pain, range of motion of shoulder joint and the SPADI score in patients with sub-acromial pain syndrome post intervention including scapulothoracic upward rotation, posterior tilting and outward rotation glide with or without combination of acromioclavicular inferior glide.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 25 - 40 years
  • Genders both male and female
  • Patients having unilateral non-traumatic shoulder pain
  • Patients having pain for ≥ 3 months
  • According to Dutch Orthopedic Association Clinical Practice Guidelines 2 out of following 3 tests should be positive i.e. Hawkin's kennedy test, Painful arc test, and Infraspinatus resistance test
  • Positive scapular assistance test
  • Positive AC joint scarf test

Exclusion Criteria

  • Patients having bilateral shoulder pain
  • Younger than 25 and older than 40 years
  • With positive drop arm test for supraspinatus tears
  • Degenerative joint disease of shoulder
  • Patients diagnosed with frozen shoulder
  • Having history of shoulder fracture and dislocation
  • Patients diagnosed with cervical radiculopathy (19)
  • Having history of shoulder or neck surgery (19)
  • Patients who had steroid injections in shoulder joint in the past 6 months
  • Patients having other neurological, orthopedic and systemic problems affecting the shoulder, neck and back

Arms & Interventions

Scapulothoracic joint mobilization with acromioclavicular joint mobilization

Experimental

Intervention: Scapulothoracic joint mobilization (Other)

Scapulothoracic joint mobilization with acromioclavicular joint mobilization

Experimental

Intervention: Acromioclavicular joint mobilization (Other)

Scapulothoracic joint mobilization with acromioclavicular joint mobilization

Experimental

Intervention: Standard physiotherapy treatment (Other)

Scapulothoracic joint mobilization

Active Comparator

Intervention: Scapulothoracic joint mobilization (Other)

Scapulothoracic joint mobilization

Active Comparator

Intervention: Standard physiotherapy treatment (Other)

Outcomes

Primary Outcomes

Numeric Pain Rating scale

Time Frame: from enrolment to the end of 4 weeks of treatment

this scale is used to evaluate pain. it consists of 11 points from 0 to 10, where 0 represents no pain, 1-3 represents mild pain, 4-6 moderate pain and 7-10 represents severe pain.

Shoulder Pain and Disability Index SPADI

Time Frame: from enrolment to the end of 4 weeks treatment

this questionnaire consisting of 13 items is used to assess the severity of pain and difficulty while performing daily life activities. two subscales for pain and disability. uses a visual Analog scale or Numeric rating scale for each item, resulting in scores from 0-100 for each sub-scale, with higher scores indicating more pain or disability.

Secondary Outcomes

  • goniometer for shoulder flexion ROM(from enrolment to the end of 4 weeks treatment)
  • Goniometer for shoulder extension ROM(from enrolment to the end of 4 weeks of treatment)
  • Goniometer for shoulder abduction ROM(from enrolment to the end of 4 weeks treatment sessions)
  • Goniometer for shoulder adduction ROM(from enrolment to the end of 4 weeks of treatment)
  • Goniometer for shoulder external rotation ROM(from enrolment to the end of 4 weeks of treatment)
  • goniometer for shoulder internal rotation ROM(from enrolment to the end of 4 weeks treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials